
CatenaBio
Developer of antibody-drug conjugates designed for the treatment of multiple diseases. The company's conjugates use protein conjugation technology that allows the attachment of any two proteins togeth...
Valuation
$0
Share Price
N/A
Total Raised
$9.1M
Last Round
N/A